02-1³í´Ü-¹ÎÁ¤Áß

Similar documents

ƯÁýc03Öâ¿î˘



김범수

Chapter 26

서강대학교 기초과학연구소대학중점연구소 심포지엄기초과학연구소

Mol_Imaging

뉴스지14호-칼라

lastreprt(....).hwp


System Biology Core

Contents 이사장 인사말 04 병원장 인사말 05 연혁 06 진료과 소개 08 젊고 건강한 삶을 되찾기 위한 새로운 시작! MH연세병원에서 만날 수 있습니다. 주요센터 소개 14 치과 소개 32 의료장비 소개 34 편의시설 38

전기일반(240~287)

<303020C1BEBCB328B1E8B5BFBEEF D E687770>

THE JOURNAL OF KOREAN INSTITUTE OF ELECTROMAGNETIC ENGINEERING AND SCIENCE Jul.; 27(7),

이주형.PDF

21세기 바이오 혁명

心臟疾病細胞治療之臨床試驗簡介

STKP.PDF

Pharmacotherapeutics Application of New Pathogenesis on the Drug Treatment of Diabetes Young Seol Kim, M.D. Department of Endocrinology Kyung Hee Univ

,,,,,,,, (), BOD,,,,,,,,,

노인의학 PDF

A

KISEP Experimental Researches J Korean Neurosurg Soc Supplement Ⅰ 30 S13-S19, 2001 아데노바이러스 Cytosine Deaminase/Thymidine Kinase 융합유전자의항종양효과 * 김영우 최재영 장

evt_down[1].pdf

이 발명을 지원한 국가연구개발사업 과제고유번호 KGM 부처명 교육과학기술부 연구관리전문기관 연구사업명 전북분원운영사업 연구과제명 저탄소 녹생성장을 위한 바이오매스/에너지 개발 주관기관 한국생명공학연구원 연구기간 2009년 01월 01일 ~ 2009년 12월

<4D F736F F F696E74202D204D5249B1E2BCFAB5BFC7E2B9D7BDC3C0E5C7F6C8B25F F325B315D205BC8A3C8AF20B8F0B5E55D>

Chapter 11

(

루게릭병을 이기는 사람들 LOU GEHRIG CLINIC HANYANG UNIVERSITY HOSPITAL 저 자 신경과 l 김승현 고성호 최원준 오기욱 오성일 루게릭전담간호팀 l 안지원 오주연 임한나 황보경 재활의학과 l 김태곤 호흡기내과 l 곽현정 영양과 l 백희준

Chapter 6. Nucleotides and Nucleic Acids 세포대사에서뉴클레오타이드 (nucleotide) 의기능은무엇인가? Objective 유전체학 (genomics) 과단백체학 (proteomics) 기본개념이해 재조합 DNA 기술 (recombin

< FC1F8B9E6B1B3C0B02E687770>

존경하는 독자 여러분!! 질병에서 해방운동(21세기 3 1운동)에 동참하면 박근혜 정부 임기이내 의료보험 1/3만 납부해도 환자분담금 없는 국민행복시대를 자손에게 물려준다. Korea OECD 회원국 중 환자증가율 의료증가율 암발생율 암사망율 40~50대 사망율 불임율

학습영역의 Taxonomy에 기초한 CD-ROM Title의 효과분석

untitled

00....

02 나 해결되지 않아 고심하던 중 미생물도 생명체이므로 약육강식하는 동물의 세 계와 같이 개구리 같은 약자와 호랑이 같은 강자가 있다는 자연의 섭리가 생각났 다. 그렇다면 호랑이 같은 미생물이 어디에 있을까? 라는 의문에 답이 나왔다. 살균력이 매우 강력한 옻나무와

Can032.hwp

3Å׸¶(12¿ùÈ£)3053.ok

Custom sirna Genepharma 는 ISO9000 품질경영시스템인증을획득하여 high quality, high purity 의 custom sirna 를생산, 제공해드립니다. 기본제공되는 duplex type 은 HPLC 정제로 unpaired single


untitled

분 기 보 고 서 (제 47 기) 사업연도 2014년 01월 01일 2014년 03월 31일 부터 까지 금융위원회 한국거래소 귀중 2014년 5월 30일 제출대상법인 유형 : 면제사유발생 : 주권상장법인 해당사항 없음 회 사 명 : 파미셀 주식회사 대 표 이 사 : 김

02 AMC News AMC 칼럼 나쁜 소식이 좋은 소식? 해외 불우환자 진료비지원 첫 수혜자 3명 캄보디아에서 방문 최재원 소장 건강증진센터 식의 부족 등으로 인해 증상이 나타난 다음에야 병원을 건강 검진이요? 괜히 병원 갔다가 나쁜 소식 듣게 될까 찾았고, 그러다

09권오설_ok.hwp

한약치료와표적항암요법 ( 아피니토 ) 을병행하여부분관해된신세포암간전이환자 1 례 Abstract Sung-Hwan Chang 1, Ji-Hye Park 1,2, Hwa Seung Yoo,2*

항체 포털 서비스 Preparation Peptide 총 4주 소요 / 473,000 ~ 511,000 Free of charge 2~3 days 243,000 ~ 281,000 의뢰서 작성 Peptide epitope prediction 유전자 정보

[ 화학 ] 과학고 R&E 결과보고서 나노입자의표면증강을이용한 태양전지의효율증가 연구기간 : ~ 연구책임자 : 김주래 ( 서울과학고물리화학과 ) 지도교사 : 참여학생 : 원승환 ( 서울과학고 2학년 ) 이윤재 ( 서울과학고 2학년 ) 임종

<30382EC0C7C7D0B0ADC1C22E687770>

untitled

High Resolution Disparity Map Generation Using TOF Depth Camera In this paper, we propose a high-resolution disparity map generation method using a lo

미래의학 - 맞춤형의학 유전자가위

농림수산식품부장관귀하 이보고서를 팥의대사성질환개선및기능성규명 에관한연구의최종보고서로제출 합니다 년 2 월 11 일 - 1 -

Kbcs002.hwp

레이아웃 1

TOYOBO Reagent 만의독보적인기술 ReverTra Ace M-MLV RTase 의 RNase H domain 에 mutation 시키므로 RNase H activity 를낮추고,mRNA 의 degradation 을막아 cdna 합성효율을높임 KOD Polyme

Chapter 11


-

PowerPoint 프레젠테이션

553호

125_134_특집_강은아_김광#4D4B32

이 발명을 지원한 국가연구개발사업 과제고유번호 SI-1304 부처명 기획예산처 연구관리전문기관 산업기술연구회 연구사업명 정부출연 일반사업 연구과제명 생명통합정보시스템 활용 독창적 신약개발협동연구사업 기 여 율 1/1 주관기관 한국화학연구원 연구기간

PowerPoint 프레젠테이션

化學科

13_1_학회소식_rev5_ hwp

핵의학

02-³í´Ü1

슬라이드 1

Cloning

hwp

<C0FCC3BC28C0DAB7E1C6ED5FC1A6BFDC292E687770>

한국전지학회 춘계학술대회 Contents 기조강연 LI GU 06 초강연 김동욱 09 안재평 10 정창훈 11 이규태 12 문준영 13 한병찬 14 최원창 15 박철호 16 안동준 17 최남순 18 김일태 19 포스터 강준섭 23 윤영준 24 도수정 25 강준희 26

Treatment and Role of Hormaonal Replaement Therapy

한약재품질표준화연구사업단 강활 ( 羌活 ) Osterici seu Notopterygii Radix et Rhizoma 생약연구과

2 HEALTH & HAPPINESS Innovative Preclinical CRO Company - Edis Biotech

hwp

ÀÌ»ó¹Î

388 The Korean Journal of Hepatology : Vol. 6. No COMMENT 1. (dysplastic nodule) (adenomatous hyperplasia, AH), (macroregenerative nodule, MR

PowerPoint Presentation

Disclaimer IPO Presentation,., Presentation,. Presentation..,,,,, E..,.,,.

PowerPoint Presentation

제호

550호(01-09)

Oligo synthesis 4 단계공정을한 cycle 로하여 1 mer 씩 3' 말단에서 5' 말단까지순차적으로합성이진행됩니다. Deblocking Coupling Capping Oxidation OPC Purification Reverse-phase chromato

최근연구소식 Molecular and Cellular Biology News 최근의연구동향을이해할수있도록몇편의논문을요약하여하나의주제로소개합니다. TGF-β 신호전달경로의새로운조절기전 Watanabe Y, Itoh S, Goto T, Ohnishi E, Inamitsu

7.ƯÁýb71ÎÀ¯È« š

2005CG01.PDF

45-51 ¹Ú¼ø¸¸


7월웹진

歯여성정책포럼.PDF

09È«¼®¿µ 5~152s

KAERIAR hwp

01 Automated Protein Expression and Purification Using ExiProgen Selection Guide 267 ExiProgen EC Protein Synthesis Kit 268 ExiProgen EC-Maxi Protein

51(2)-06.fm

03-ÀÌÁ¦Çö

Benchtop Flow Cytometry guava easycyte Systems 머크밀리포아의 guava easycyte System 은특허받은 microcapillary 기술을이용한컴팩트한시스템으로다양하고복잡한세포분석이가능합니다. Cell Health Cell S

Overview -ingredient - mechanism 2. Biomarker 3. In vitro study 4. In vivo study 5. Human study 6. 기능성 인정서 7.기준규격 인정서

Transcription:

Tel. 061-379-7271 / Fax. 061-379-7280 / E-mail. jjmin@chonnam.ac.kr (molecular biology), (cell biology) (non-invasive in vivo imaging) / (1-4). (fluorescence), (bioluminescence), SPECT, PET, MRI,, / ( 1). (translational research). [ 18 F]-FDG ([ 18 F]2-deoxy-2-fluoro-D-glucose) PET. (molecular photonic imaging) (photon) (PET), (optical imaging). 1. multimodal molecular imaging. PET, CT, MRI, micropet, microct, animal MRI, high frequency US bioluminescence system, fluorescence sytem. (1) PET ( ) / 21

PET (specific marker).,, natural biological molecule,, molecular probe, reporter probe, marker, tracer. PET, molecule. probe PET, ( 2). [ 18 F]2-deoxy- 2-fluoro-D-glucose (FDG) fluorine-18 ( 18 F). PET 18 F FDG, probe (intravascular compartment) (extravascular compartment) (intracellular compartment). FDG, (glucose transporter) hexokinase II. FDG hexokinase II, hexokinase II. FDG 18 F. (annihilation event), 511 kev 180. (scintillation crystal) (photomultiplier tube) PET. (annihilation event) (coincident event). PET (50,000~100,000). FDG, filtered-back projection (attenuation correction).,,, FDG. PET 18 F 11 C, 15 O, 13 N, 14 O, 64 Cu, 62 Cu, 124 I, 82 Rb, 68 Ga, 76 Br. (cyclotron), ( 18 F 110 ).. PET micropet. PET 6 3 ~8 3 mm 3, PET ~3 3 mm 3. micropet ~2 3 mm 3, ~1 3 mm 3 micropet. PET 10-11 ~10-12 M/L. MRI 10-4 ~10-5 M/L., (optical image). PET 10 6 10 9. PET 2. PET 22

,, (5). (2) In Vivo (In Vivo Optical Imaging) in vitro ex vivo, luminometer. in vivo imaging. bioluminescence (targeted bioluminescence probe), (nearinfrared fluorochrome), (activatable near-infrared fluorochrome), (red-shifted fluorescence protein)...,. (charged coupled device, CCD). silicon-based detector. 400-1000nm, 2-3 ev CCD. CCD. CCD CCD chip thermal noise. Thermal noise CCD chip 20 C 10, CCD -120~-150 C (cooled CCD)., CCD. CCD (1). CCD.,.,,., cooled CCD 2. rotating CCD, single CCD volumetric image. CCD PM tube (6). 1) In Vivo Bioluminescence in vivo bioluminescence (, bacteria,,, ) (luciferase). luciferase,,,, 3. Bioluminescence /. Firefly luciferase (fluc) Luciferase D-luciferin. fluc D-luciferin. fluc. 23

, ATP.. luciferase.,, - ( 3). luciferase mammalian tissue. 600nm,., 600~1100nm. luciferase Photinus Pyralis firefly luciferase (Fluc), 560nm 600nm in vivo. Fluc D-luciferin oxyluciferin.,, ATP (7). bioluminescence -. (1) Fluc (external light excitation), D-luciferin, ATP,,. (2) D-luciferin turnover (T 1/2 =3h). (3). Fluc. 2) In Vivo Fluorescence Fluorescence (395~600nm), CCD. (, green fluorescence protein; GFP) in vivo. GFP 395nm 509nm. GFP EGFP (enhanced GFP) GFP 35. Coral discosoma red fluorescence protein (RFP) 558nm 583nm. Bioluminescence fluorescence autofluorescence. in vivo (1, 7). (Near-infrared fluorescent dye) Fluorescence protein, fluorescent dye in vivo. 700~900nm.,, (600~1000nm). Weissleder dye. Cathepsin B & H, matrix metalloprotease-2 (MMP-2) (8, 9). Fluorophores GFP RFP Cy5.5 ICG (indocyanine green) (excitation wavelength) 395-490nm 500-550nm 620-670nm 710-785nm (emission wavelength) 500-575nm 575-650nm 695-770nm 810-885nm 24

(1) (reporter gene). chloramphenicol acetyl transferase (CAT), alkaline phosphatase, α-galactosidase (lac Z).,,,,. green fluorescent protein (GFP) luciferase.,. PET,,. (reporter probe) (reporter gene) (10, 11). (2) /. 1). 2). 3). 4). 5). (.) 6). 7). 8). 9). ( 7 Kb.) 10). 11) mrna/. 12),. /.,. /. (3) PET 1) Cytosine deaminase Cytosine deaminase (CD) cytosine uracil. CD cytosine uracil. CD 5-25

fluorocytosine 5-fluorouracil CD 5-fluorocytosine. CD 6-[ 3 H]-5-fluorocytosine CD (human glioblastoma) 6-[ 3 H]-5-fluorouracil. 6-[ 3 H]-5-fluorocytosine. CD (10).. HSV1-TK, thymidine ( ; 5-iodo- 2-fluoro-2-deoxy-1-â-D-arabinofuranosyl-5-iodouracil (FIAU)) acyclogunosine ( ; 9-(4-[ 18 F]-fluoro-3-hydroxymethylbutyl)-guanine ([ 18 F]FHBG)) ( 4). HSV1-TK. Thymidine FIAU [ 131 I] [ 124 I], HSV1-TK 2) Herpes-simplex virus type-1 thymidine kinase thymidine kinase. ATP deoxythymidine deoxythymidine monophosphate (dtmp). (herpes simplex virus) thymidine kinase (herpes simplex virus thymidine kinase, HSV-TK) ( HSV1-TK, HSV1-tk.). thymidine kinase thymidine kinase deoxythymidine,. (12). Acyclovir (9-(2-hydroxyethoxymethyl)guanine) HSV- TK. HSV-TK acyclovir monophosphate guanylate kinase acyclovir diphosphate, acyclovir triphosphate. Acyclovir triphosphate DNA DNA DNA polymerase DNA. HSV1-TK gancyclovir (9-[[2-hydroxy-1-(hydroxymethyl)ethoxy] methyl]guanine) pencyclovir (9-(4-hydroxy-3-hydroxymethylbutyl)guanine). HSV1- tk, 4. HSV-tk TdR (thymidine), 5-methyluracil-2 -deoxyribose; FIAU, 2 -fluoro-2 -deoxy-b-d-arabinofuranosyl-5-iodouracil; FIRU, 2 -fluoro-2 -deoxy-5-iodo-1-b-d-ribofuranosyl-uracil; FMAU, 2 -fluoro-2 -deoxy-5-methyl-1-b-d-arabinofuranosyluracil; FEAU, 2 -fluoro-2 -deoxyarabinofuranosyl-5-ethyluracil; IVFRU, 2 -fluoro-2 -deoxy-5-iodovinyl-1-b-ribofuranosyl-uracil; IUdR, 2 -deoxy-5-iodo-1-b-d-ribofuranosyl-uracil; ACV, 9-[(2-hydroxy-1-ethoxy)methyl]guanine (acyclovir); GCV, 9-[(2-hydroxy-1-(hydroxymethyl)ethoxy)methyl]guanine (ganciclovir); PCV, 9-[4-hydroxy-3-(hydroxymethyl)butyl]guanine (penciclovir); FGCV, 8-fluoro-9-[(2-hydroxy-1-(hydroxymethyl)ethoxy)methyl] guanine (fluoroganciclovir); FPCV, 8-fluoro-9-[4-hydroxy-3-(hydroxymethyl)butyl]guanine (fluoropenciclovir); FHPG, 9-[(3-fluoro-1-hydroxy-2-propoxy)methyl]guanine; FHBG, 9-(4-fluoro-3-hydroxymethylbutyl)guanine. 26

. HSV1-tk [ 124 I]FIAU. FIAU acycloguanosine derivatives HSV1-TK, TK (13, 14). Acycloguanosine acyclovir (ACV) ganciclovir (GCV), penciclovir (PCV) HSV1-TK, PCV [ 18 F] [ 18 F]FHBG (15, 16). HSV1-tk HSV1-sr39tk acycloguanosine HSV1-tk FIAU (17). 3) -2-2 (dopamine-2 receptor, D 2 R) striatum. D2R D 2 R 3-(2-[ 18 F]-fluoroethyl)spiperone ([18F]FESP) PET, [ 123 I]iodobenzamine SPECT (18). PET / D 2 R [ 18 F]FESP D 2 R mrna.. (19). D 2 R G (G gycoprotein coupled receptor, GPCR) (secondary messenger) protein kinase.. 4) Human type 2 somatostatin receptor (hsstr2) hsstr2. [ 111 In]Octreotide, [ 99m Tc]P829, and [ 99m Tc]P2045, hsstr2 [ 99m Tc]P2045 (20). 5) Sodium/iodide symporter sodium/iodide symporter (NIS). ([ 123 I], [ 131 I]) [ 99m Tc]pertechnetate.., NIS (21). (4) (Optical Imaging) 1) Firefly luciferase luciferase Photinus Pyralis firefly luciferase (Fluc), 560nm 600nm in vivo. Fluc D-luciferin oxyluciferin.,, ATP. Fluc -, in vivo luciferin 20.,,, 1. ATP (22). 2) Renilla luciferase renillar reniformis Fluc luciferase renilla luciferase (Rluc) 27

. coelenterazine enthalpy. Fluc,, ATP, ATP. Fluc - in vivo. coelenterazine. 480 nm, 600 nm (23, 24). 3) Gaussia luciferase Gausia princeps renilla luciferase luciferase (25). Gaussia luciferase (Gluc). Gluc Rluc coelenterazine. (quantum yield) Rluc 200 Fluc, Rluc 480 nm. 4) Bacterial luciferase Vibrio harveyi, Vibrio fischeri, Photorhabdus luminescens lux A, B, C, D, E (operon) lux A, lux B bacterial luciferase lux C, lux D, lux E fatty acid reductase enzyme complex. reduced flavin mononucleotide (FMNH 2 ) 490 nm. luciferase, bacterial operon (26). 5) Green fluorescence protein Green fluorescence protein (GFP) Aequorea victoria. cofactor (excitation wavelength),. 450-490 nm 510-570 nm.?,, GFP. GFP (27). 6) Red fluorescence protein R. Tsien discosoma DsRed DNA. 500-550 nm 575-650 nm. 600nm. DsRed tetramer monomeric red flurescence protein (28). (1). 1) PET SPECT, 2) MRI, 3) PET ( 5) (29). 1) (I-124, Cu- 64, In-111, I-123, Tc-99m ), SPECT, PET.,,., 28

, 48 75%.,,. 2) MRI MRI. MRI,.,,, 2., MRI, (30). 3) PET,.,.,,,., (31). (2) Bacterial luciferase in vivo (In Vivo 5.. ( ) In-111.,. ( ) MRI.. ( ) firefly luciferase PET HSV1-tk, PET.. Imaging of Light-Emitting Bacteria) In vivo bioluminescence. bacterial luciferase (Lux) soil bacterium Photorhabdus luminescens lux operon. lux operon 5, lux A, B luciferase, lux C, D, E 3. firefly luciferase. lux 500nm. (light-emitting bacteria),. lux operon. 29

1) IRES (IRES based approach) internal ribosomal entry sites (IRES)... IRES. 6.. lux, 6. GFP. H&E (A) Gram (B), DAPI, Texas red F-actin (C-H) 1 (C, D), 5 (E, F), 7 (G, H). (C, E, G; 600 D, F, H; 1200 ), ( 6) (26, 32). 2) (Fusion gene approach) (fusion gene).,. 3) (Dual-promoter approach). IRES,,. (3) (Imaging Gene Therapy). ( 7).. (33). 4) (Co-administration approach).,.. 5) (Bidirectional transcriptional approach) Tetracycline-responsive element (TRE) minimal 30

7. 5 CMV. TRE rtetr-vp16 transactivator, rtetr-vp16 tetracycline doxycycline TRE. IRES,., (imaging of bi-directional inducible gene expression). (4) (Imaging Transcriptional Regulation) constitutive promoter CMV... Green. (endogenous gene) 8. 2 (Two-step transcriptional amplification system, TSTA).. GAL-4/VP-16 GAL-4 2. 1 GAL-4/VP-16. GAL-4/VP-16 2 GAL-4 VP-16. (, CEA, PSA, p53) (34). /. (transcription activation domain) VP16 DNA GAL4, GAL4 2 (Two step transcriptional amplification system, TSTA system) ( 8). TSTA 12~15 (35-37)., PSA (key regulating element) (multimerization) 31

(34). (5).,.,. (adoptive immunotherapy),., (38)., PET SPECT,,...,. PET 6. PET [ 64 Cu]pyruvaldehydebis(N4-methylthiosemicarbazone) ([ 64 Cu]PTSM) (39).,...,. HSV1-tk, NIS, Fluc, (38). (6) (Molecular Interaction Imaging), GAL4-VP16 TSTA.,. Ray NF-kB (VP16-MyoD GAL4-ID) (40). Paulmurugan (41-43). (7) (Near-infrared fluorescent dye) cathepsin B & H, matrix metalloprotease-2 (MMP-2). µm (quenched)., (unquenched). indocyanine green (ICG) cy5.5 fluorescent dye,. smart probe, (, ) (44-46). PET,,.,,. 32

PET MRI.,,,.,,,,. PET FDG. PET (47). PET PET.,. 1. Massoud, T. F. and Gambhir, S. S. (2003) Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 17, 545-580. 2. Weissleder, R. and Mahmood, U. (2001) Molecular imaging. Radiology 219, 316-333. 3. (2004). 38, 143-150. 4. (2004). 38, 111-114. 5. Biswal, S. (2003) Molecular imaging of musculoskeletal diseases. Semin Musculoskelet Radiol 7, 317-350. 6. Chen, Y., Intes, X., and Chance, B. (2005) Development of high-sensitivity near-infrared fluorescence imaging device for early cancer detection. Biomed Instrum Technol 39, 75-85. 7. Contag, C. H. and Bachmann, M. H. (2002) Advances in in vivo bioluminescence imaging of gene expression. Annu Rev Biomed Eng 4, 235-260. 8. Bremer, C., Tung, C. H., and Weissleder, R. (2001) In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat Med 7, 743-748. 9. Mahmood, U. and Weissleder, R. (2003) Nearinfrared optical imaging of proteases in cancer. Mol Cancer Ther 2, 489-496. 10. Gambhir, S. S., Barrio, J. R., Herschman, H. R., and Phelps, M. E. (1999) Assays for noninvasive imaging of reporter gene expression. Nucl Med Biol 26, 481-490. 11. Gambhir, S. S., Herschman, H. R., Cherry, S. R., Barrio, J. R., Satyamurthy, N., Toyokuni, T., Phelps, M. E., Larson, S. M., Balatoni, J., Finn, R., Sadelain, M., Tjuvajev, J., and Blasberg, R. (2000) Imaging transgene expression with radionuclide imaging technologies. Neoplasia 2, 118-138. 12. Gambhir, S. S., Barrio, J. R., Wu, L., Iyer, M., Namavari, M., Satyamurthy, N., Bauer, E., Parrish, C., MacLaren, D. C., Borghei, A. R., Green, L. A., Sharfstein, S., Berk, A. J., Cherry, S. R., Phelps, M. E., and Herschman, H. R. (1998) Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir. J Nucl Med 39, 2003-2011. 13. Tjuvajev, J. G., Avril, N., Oku, T., Sasajima, T., Miyagawa, T., Joshi, R., Safer, M., Beattie, B., DiResta, G., Daghighian, F., Augensen, F., Koutcher, J., Zweit, J., Humm, J., Larson, S. M., Finn, R., and Blasberg, R. (1998) Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res 58, 4333-4341. 14. Tjuvajev, J. G., Doubrovin, M., Akhurst, T., Cai, S., Balatoni, J., Alauddin, M. M., Finn, R., Bornmann, W., Thaler, H., Conti, P. S., and Blasberg, R. G. (2002) Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression. J Nucl Med 43, 1072-1083. 15. Iyer, M., Barrio, J. R., Namavari, M., Bauer, E., Satyamurthy, N., Nguyen, K., Toyokuni, T., Phelps, M. E., Herschman, H. R., and Gambhir, S. S. (2001) 8-[18F]Fluoropenciclovir: an improved reporter probe for imaging HSV1-tk reporter gene expression in vivo using PET. J Nucl Med 42, 96-105. 16. Min, J. J., Iyer, M., and Gambhir, S. S. (2003) Com- 33

parison of [18F]FHBG and [14C]FIAU for imaging of HSV1-tk reporter gene expression: adenoviral infection vs stable transfection. Eur J Nucl Med Mol Imaging 30, 1547-1560. 17. Gambhir, S. S., Bauer, E., Black, M. E., Liang, Q., Kokoris, M. S., Barrio, J. R., Iyer, M., Namavari, M., Phelps, M. E., and Herschman, H. R. (2000) A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. Proc Natl Acad Sci U S A 97, 2785-2790. 18. Herschman, H. R., MacLaren, D. C., Iyer, M., Namavari, M., Bobinski, K., Green, L. A., Wu, L., Berk, A. J., Toyokuni, T., Barrio, J. R., Cherry, S. R., Phelps, M. E., Sandgren, E. P., and Gambhir, S. S. (2000) Seeing is believing: non-invasive, quantitative and repetitive imaging of reporter gene expression in living animals, using positron emission tomography. J Neurosci Res 59, 699-705. 19. Liang, Q., Satyamurthy, N., Barrio, J. R., Toyokuni, T., Phelps, M. P., Gambhir, S. S., and Herschman, H. R. (2001) Noninvasive, quantitative imaging in living animals of a mutant dopamine D2 receptor reporter gene in which ligand binding is uncoupled from signal transduction. Gene Ther 8, 1490-1498. 20. Zinn, K. R. and Chaudhuri, T. R. (2002) The type 2 human somatostatin receptor as a platform for reporter gene imaging. Eur J Nucl Med Mol Imaging 29, 388-399. 21. Chung, J. K. (2002) Sodium iodide symporter: its role in nuclear medicine. J Nucl Med 43, 1188-1200. 22. Contag, C. H., Spilman, S. D., Contag, P. R., Oshiro, M., Eames, B., Dennery, P., Stevenson, D. K., and Benaron, D. A. (1997) Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem Photobiol 66, 523-531. 23. Bhaumik, S. and Gambhir, S. S. (2002) Optical imaging of Renilla luciferase reporter gene expression in living mice. Proc Natl Acad Sci U S A 99, 377-382. 24. Bhaumik, S., Lewis, X. Z., and Gambhir, S. S. (2004) Optical imaging of Renilla luciferase, synthetic Renilla luciferase, and firefly luciferase reporter gene expression in living mice. J Biomed Opt 9, 578-586. 25. Tannous, B. A., Kim, D. E., Fernandez, J. L., Weissleder, R., and Breakefield, X. O. (2005) Codonoptimized Gaussia luciferase cdna for mammalian gene expression in culture and in vivo. Mol Ther 11, 435-443. 26. Min, J. J., Moon, S. M., Hong, Y. J., Cho, K. O., Bom, H. S., and Choy, H. E. (2005) Detection of solid tumor using light-emitting E. coli. Mol Imaging Biol 7, 144. 27. Hoffman, R. M. (2004) Imaging tumor angiogenesis with fluorescent proteins. Apmis 112, 441-449. 28. Shaner, N. C., Campbell, R. E., Steinbach, P. A., Giepmans, B. N., Palmer, A. E., and Tsien, R. Y. (2004) Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat Biotechnol 22, 1567-1572. 29. Wu, J. C., Tseng, J. R., and Gambhir, S. S. (2004) Molecular imaging of cardiovascular gene products. J Nucl Cardiol 11, 491-505. 30. Kraitchman, D. L., Heldman, A. W., Atalar, E., Amado, L. C., Martin, B. J., Pittenger, M. F., Hare, J. M., and Bulte, J. W. (2003) In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 107, 2290-2293. 31. Wu, J. C., Chen, I. Y., Sundaresan, G., Min, J. J., De, A., Qiao, J. H., Fishbein, M. C., and Gambhir, S. S. (2003) Molecular imaging of cardiac cell transplantation in living animals using optical bioluminescence and positron emission tomography. Circulation 108, 1302-1305. 32. Yu, Y. A., Shabahang, S., Timiryasova, T. M., Zhang, Q., Beltz, R., Gentschev, I., Goebel, W., and Szalay, A. A. (2004) Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins. Nat Biotechnol 22, 313-320. 33. Min, J. J. and Gambhir, S. S. (2004) Gene therapy progress and prospects: noninvasive imaging of gene therapy in living subjects. Gene Ther 11, 115-125. 34. Adams, J. Y., Johnson, M., Sato, M., Berger, F., Gambhir, S. S., Carey, M., Iruela-Arispe, M. L., and Wu, L. (2002) Visualization of advanced human prostate cancer lesions in living mice by a targeted gene transfer vector and optical imaging. Nat Med 8, 891-897. 35. Iyer, M., Salazar, F. B., Lewis, X., Zhang, L., Carey, 34

M., Wu, L., and Gambhir, S. S. (2004) Noninvasive imaging of enhanced prostate-specific gene expression using a two-step transcriptional amplificationbased lentivirus vector. Mol Ther 10, 545-552. 36. Iyer, M., Salazar, F. B., Lewis, X., Zhang, L., Wu, L., Carey, M., and Gambhir, S. S. (2005) Non-invasive imaging of a transgenic mouse model using a prostate-specific two-step transcriptional amplification strategy. Transgenic Res 14, 47-55. 37. Iyer, M., Wu, L., Carey, M., Wang, Y., Smallwood, A., and Gambhir, S. S.(2001) Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters. Proc Natl Acad Sci U S A 98, 14595-14600. 38. Hardy, J., Edinger, M., Bachmann, M. H., Negrin, R. S., Fathman, C. G., and Contag, C. H. (2001) Bioluminescence imaging of lymphocyte trafficking in vivo. Exp Hematol 29, 1353-1360. 39. Adonai, N., Nguyen, K. N., Walsh, J., Iyer, M., Toyokuni, T., Phelps, M. E., McCarthy, T., McCarthy, D. W., and Gambhir, S. S. (2002) Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4- methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. Proc Natl Acad Sci U S A 99, 3030-3035. 40. Ray, P., Pimenta, H., Paulmurugan, R., Berger, F., Phelps, M. E., Iyer, M., and Gambhir, S. S. (2002) Noninvasive quantitative imaging of protein-protein interactions in living subjects. Proc Natl Acad Sci U S A 99, 3105-3110. 41. Paulmurugan, R. and Gambhir, S. S. (2005) Firefly luciferase enzyme fragment complementation for imaging in cells and living animals. Anal Chem 77, 1295-1302. 42. Paulmurugan, R., Massoud, T. F., Huang, J., and Gambhir, S. S. (2004) Molecular imaging of drugmodulated protein-protein interactions in living subjects. Cancer Res 64, 2113-2119. 43. Paulmurugan, R., Umezawa, Y., and Gambhir, S. S. (2002) Noninvasive imaging of protein-protein interactions in living subjects by using reporter protein complementation and reconstitution strategies. Proc Natl Acad Sci U S A 99, 15608-15613. 44. Tung, C. H., Bredow, S., Mahmood, U., and Weissleder, R. (1999) Preparation of a cathepsin D sensitive near-infrared fluorescence probe for imaging. Bioconjug Chem 10, 892-896. 45. Tung, C. H., Gerszten, R. E., Jaffer, F. A., and Weissleder, R.(2002) A novel near-infrared fluorescence sensor for detection of thrombin activation in blood. Chembiochem 3, 207-211. 46. Tung, C. H., Mahmood, U., Bredow, S., and Weissleder, R. (2000) In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res 60, 4953-4958. 47. Penuelas, I., Mazzolini, G., Boan, J. F., Sangro, B., Marti-Climent, J., Ruiz, M., Ruiz, J., Satyamurthy, N., Qian, C., Barrio, J. R., Phelps, M. E., Richter, J. A., Gambhir, S. S., and Prieto, J. (2005) Positron emission tomography imaging of adenoviral-mediated transgene expression in liver cancer patients. Gastroenterology 128, 1787-1795. 35